Is NHEJ a tumor suppressor or an aging suppressor?

Area of Science:

• Genetics
• Molecular Biology
• Aging Research

Background:

• Tumor suppressors are vital genes for early life fitness, categorized as caretakers (DNA repair) and gatekeepers (cell cycle control).
• Gatekeepers like p53 halt cell cycles or induce apoptosis/senescence to manage DNA damage, protecting the organism.
• Nonhomologous end joining (NHEJ) is a DNA repair pathway that fixes double-strand breaks, preventing chromosomal instability.

Purpose of the Study:

• To examine the role of Nonhomologous end joining (NHEJ) in aging and cancer.
• To propose that NHEJ evolved to reduce genomic instability and mitigate potentially harmful cellular responses.
• To challenge the classification of NHEJ as a primary tumor suppressor.

Main Methods:

• Review of existing literature on NHEJ, DNA repair, aging, and cancer.
• Analysis of phenotypes in NHEJ-mutant mice, including increased GCRs and premature aging.
• Comparative analysis of NHEJ function versus gatekeeper pathways.

Main Results:

• NHEJ-mutant mice exhibit increased gross chromosomal rearrangements (GCRs) but not necessarily increased cancer incidence.
• NHEJ-mutant mice display characteristics of premature aging.
• The study suggests NHEJ's primary role is genomic stability and moderation of aging, not direct tumor suppression.

Conclusions:

• NHEJ evolved to prevent GCRs and temper gatekeeper-induced aging.
• Observed tumor suppression linked to NHEJ may be indirect or a result of experimental bias.
• Re-evaluating NHEJ's function beyond a caretaker role is necessary.